Kyn Therapeutics Banks $49M to Advance Cancer Immunometabolism Therapies Post author:Sam Post published:December 13, 2017 Post category:BioPharma Investors were Atlas Venture and OrbiMed. Source: BioSpace You Might Also Like Adocia Announces First Quarter 2017 Financial Results April 17, 2017 Alere Achieves FDA Clearance for Alere Reader Platform and Alere BinaxNOW Influenza A & B Card 2 April 10, 2017 FDA Approves 23andMe’s Direct-to-Consumer Genetic Test for Cancer March 6, 2018
Alere Achieves FDA Clearance for Alere Reader Platform and Alere BinaxNOW Influenza A & B Card 2 April 10, 2017
